000 | 01864 a2200493 4500 | ||
---|---|---|---|
005 | 20250514054816.0 | ||
264 | 0 | _c20030902 | |
008 | 200309s 0 0 eng d | ||
022 | _a0934-9723 | ||
024 | 7 |
_a10.1007/s10096-002-0827-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeegaard, T M | |
245 | 0 | 0 |
_aDo HIV-seropositive patients become colonised with drug-resistant microorganisms? _h[electronic resource] |
260 |
_bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _cDec 2002 |
||
300 |
_a856-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnti-Bacterial Agents |
650 | 0 | 4 |
_aAnti-Infective Agents _xpharmacology |
650 | 0 | 4 |
_aAntifungal Agents _xpharmacology |
650 | 0 | 4 |
_aCandida _xdrug effects |
650 | 0 | 4 | _aDrug Resistance, Bacterial |
650 | 0 | 4 | _aDrug Resistance, Fungal |
650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHIV |
650 | 0 | 4 |
_aHIV Infections _xcomplications |
650 | 0 | 4 |
_aHaemophilus influenzae _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aStaphylococcus _xdrug effects |
650 | 0 | 4 |
_aStreptococcus pneumoniae _xdrug effects |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aCaugant, D A | |
700 | 1 | _aFrøholm, L O | |
700 | 1 | _aHøiby, E A | |
700 | 1 | _aRønning, E J | |
700 | 1 | _aSandven, P | |
700 | 1 | _aBruun, J N | |
773 | 0 |
_tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _gvol. 21 _gno. 12 _gp. 856-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10096-002-0827-9 _zAvailable from publisher's website |
999 |
_c12328273 _d12328273 |